BioSpace News Archive

Business

Premier, Inc. Declares Quarterly Cash Dividend - October 21, 2022

Premier, Inc., a leading technology-driven healthcare improvement company, announced that its Board of Directors declared a cash dividend of $0.21 per share of Class A common stock issued and outstanding.

October 21, 2022
·
1 min read
Altamira Therapeutics Announces Divestiture of Inner Ear Development Assets

Definitive agreement to sell 90% stake in Company’s Zilentin subsidiary with option to acquire all of Altamira’s remaining inner ear development assets in Q4 2022.

October 21, 2022
·
7 min read
Drug Development

BriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing

BriaCell has successfully completed its Phase I safety and tolerability evaluation of Bria-IMT™ in combination with Incyte’s retifanlimab in advanced breast cancer.

October 21, 2022
·
4 min read
Avricore to Present at Emerging Growth Conference on Oct. 26, 2022

AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ AVCR ”) is excited to present at the Emerging Growth Conference on October 26th..

October 21, 2022
·
5 min read
INVOcell Review Published in Current Opinion in Obstetrics and Gynecology

INVO Bioscience, Inc. today announced the publication of a review discussing existing literature and current use of intravaginal culture (IVC) as an option for patients seeking fertility therapies.

October 21, 2022
·
3 min read
Bio NC

HEMOSONICS APPOINTS DR. BRUCE SPIESS AS MEDICAL DIRECTOR AND EXHIBITS DIAGNOSTIC SOLUTIONS AT ANESTHESIOLOGY®, THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS (ASA) ANNUAL MEETING

Newly appointed Medical Director, Bruce Spiess, MD, FAHA to moderate the educational session “Listening to the Blood: An Update on the Quantra® System, the Latest Technology in the Management of Critical Bleeding”

October 21, 2022
·
4 min read
Business

SmartSkin Adds Global Pharma Veteran Martin VanTrieste to Board of Directors

Onshoring pharmaceutical manufacturing has become a priority in the United States and is even backed by a $2 billion federal investment.

October 21, 2022
·
3 min read
Data from Roll-In Cohort of North American pivotal alfapump® study (POSEIDON) selected for poster presentation at AASLD The Liver Meeting®

Sequana Medical NV announces that data from the Roll-In Cohort of POSEIDON1, its North American pivotal alfapump study, have been selected for a poster presentation at the American Association for the Study of Liver Diseases The Liver Meeting, taking place in Washington, DC from 4 to 8 November 2022.

October 21, 2022
·
5 min read
Calliditas Therapeutics’ nomination committee composition for the AGM 2023

Calliditas Therapeutics AB publishes the nomination committee’s composition for the AGM in 2023.

October 21, 2022
·
2 min read
Policy

Lannett Receives FDA Approval to Manufacture Numbrino® at Seymour Plant

Lannett Company, Inc. announced that it has received approval from the US Food and Drug Administration to manufacture Numbrino®, the company’s branded topical anesthetic product, at its main plant in Seymour, Indiana.

October 21, 2022
·
2 min read